Viemed Healthcare

VMD

Börsenwert 361 Mio. $

Investors need to pay close attention to VMD stock based on the movements in the options market lately.

Lafayette, Louisiana--(Newsfile Corp. - October 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Viemed Healthcare, Inc. is scheduled to present on Tuesday, October 20, 2026 at 12:30 PM PT.

Viemed Healthcare (VMD) is evolving from a capital-intensive respiratory equipment company into a diversified, capital-light home healthcare provider. VMD's expansion into sleep, resupply, and women's health segments is driving robust revenue growth while reducing capital intensity and supporting free cash flow acceleration. Despite margin compression from the new business mix, VMD needs only 0.5% annual free cash flow growth to justify its current valuation, offering a strong margin of safety.

Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.

Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.

LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.

LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.